In vitro-Empfindlichkeitstestungen für Moxifloxacin bei verschiedenen nicht-tuberkulösen Mykobakterienspezies
Thomas S. Weiß(Sigmund Freud Privatuniversität Wien), TT Bauer(Helios Klinikum Emil von Behring), N Schönfeld(Helios Klinikum Emil von Behring), T. Bergmann(Helios Klinikum Emil von Behring), Torsten Blum(MSB Medical School Berlin), Holger Rüssmann(Helios Klinikum Emil von Behring), H. Mauch(Helios Klinikum Emil von Behring)
Cited by 0
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition
|Bioinformatics|2006|331
MultiLoc2: integrating phylogeny and Gene Ontology terms improves subcellular protein localization prediction
|BMC Bioinformatics|2009|316
Fatal Outcome in Acute Pancreatitis: Its Occurrence and Early Prediction
|Pancreatology|2001|169
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
|Pneumologie|2010|166